Logo image of ZSPC

ZSPACE INC (ZSPC) Stock Fundamental Analysis

NASDAQ:ZSPC - Nasdaq - US98980W1071 - Currency: USD

13.28  +0.91 (+7.36%)

Fundamental Rating

1

ZSPC gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 71 industry peers in the Diversified Consumer Services industry. ZSPC may be in some trouble as it scores bad on both profitability and health. ZSPC is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

ZSPC had negative earnings in the past year.
ZSPC Yearly Net Income VS EBIT VS OCF VS FCFZSPC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 -5M -10M -15M

1.2 Ratios

ZSPC has a Return On Assets of -87.44%. This is amonst the worse of the industry: ZSPC underperforms 90.63% of its industry peers.
Industry RankSector Rank
ROA -87.44%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ZSPC Yearly ROA, ROE, ROICZSPC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 0 50 -50

1.3 Margins

ZSPC's Gross Margin of 38.46% is on the low side compared to the rest of the industry. ZSPC is outperformed by 60.94% of its industry peers.
ZSPC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 38.46%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ZSPC Yearly Profit, Operating, Gross MarginsZSPC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 0 20 -20 -40

1

2. Health

2.1 Basic Checks

ZSPC does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ZSPC remains at a similar level compared to 1 year ago.
ZSPC has a better debt/assets ratio than last year.
ZSPC Yearly Shares OutstandingZSPC Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 5M 10M 15M 20M
ZSPC Yearly Total Debt VS Total AssetsZSPC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 10M 20M 30M 40M

2.2 Solvency

Based on the Altman-Z score of -23.01, we must say that ZSPC is in the distress zone and has some risk of bankruptcy.
ZSPC has a Altman-Z score of -23.01. This is amonst the worse of the industry: ZSPC underperforms 89.06% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -23.01
ROIC/WACCN/A
WACC10.05%
ZSPC Yearly LT Debt VS Equity VS FCFZSPC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 0 -10M -20M -30M -40M

2.3 Liquidity

ZSPC has a Current Ratio of 0.50. This is a bad value and indicates that ZSPC is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of ZSPC (0.50) is worse than 85.94% of its industry peers.
ZSPC has a Quick Ratio of 0.50. This is a bad value and indicates that ZSPC is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.39, ZSPC is doing worse than 89.06% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.5
Quick Ratio 0.39
ZSPC Yearly Current Assets VS Current LiabilitesZSPC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 20M 40M 60M

1

3. Growth

3.1 Past

ZSPC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 14.09%, which is quite good.
Looking at the last year, ZSPC shows a very strong growth in Revenue. The Revenue has grown by 22.74%.
EPS 1Y (TTM)14.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)22.74%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ZSPC Yearly Revenue VS EstimatesZSPC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 10M 20M 30M 40M
ZSPC Yearly EPS VS EstimatesZSPC Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ZSPC. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ZSPC Price Earnings VS Forward Price EarningsZSPC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ZSPC Per share dataZSPC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ZSPC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ZSPACE INC

NASDAQ:ZSPC (2/27/2025, 8:20:19 PM)

13.28

+0.91 (+7.36%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners7.14%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner Change100%
Market Cap303.45M
AnalystsN/A
Price TargetN/A
Short Float %0.19%
Short Ratio0.44
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.91
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.55
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS1.92
BVpS-1.22
TBVpS-1.22
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -87.44%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 38.46%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover2.95
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.5
Quick Ratio 0.39
Altman-Z -23.01
F-ScoreN/A
WACC10.05%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)22.74%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y13.01%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y28.03%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y27.99%
OCF growth 3YN/A
OCF growth 5YN/A